Ascend Wellness Holdings (AAWH) Share-based Compensation Growth (3y) (2023 - 2026)
Ascend Wellness Holdings (AAWH) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 10.35% |
| 3 | Zoetis | 32.69 Bn | 30.75 Bn | 1.62 Bn | 24.36% |
| 4 | Takeda Pharmaceutical | 27.61 Bn | 23.55 Bn | 4.39 Bn | 3.84% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 88.54% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | 23.49% |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn | 11.76% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 20.51% |
| 10 | Ascend Wellness Holdings | 77.94 Mn | 17.02 Mn | 44.88 Mn | 65.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.10% |
| Sep 30, 2025 | 44.57% |
| Jun 30, 2025 | -53.91% |
| Dec 31, 2024 | 29.37% |
| Sep 30, 2024 | -49.41% |
| Jun 30, 2024 | 60.37% |
| Mar 31, 2024 | 62.72% |
| Dec 31, 2023 | 157.68% |
| Sep 30, 2023 | 480.32% |
| Mar 31, 2023 | -18.54% |